https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GlaxoSmithKline-GSK-receives-approval-for-Encruse-Ellipta-in-Japan-for-the-treatment-of-COPD-20090233/?utm_source=telegram&utm_medium=social&utm_campaign=share